Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis
|Published in||Current Alzheimer Research. 2015, vol. 12, no. 8, p. 761-71|
|Abstract||The effects of anti-dementia drugs on gait performance in Alzheimer disease (AD) are questionable. The objective of this meta-analysis was to examine the effects of anti-dementia drugs on the mean value and the coefficient of variation (CoV) of stride time among patients with AD while taking into account the type of drugs (i.e., acetylcholinesterase inhibitors [AChEIs] versus memantine) and the walking conditions (i.e., single versus dual-task).|
|Keywords||Alzheimer Disease/complications/drug therapy — Cognition Disorders/drug therapy/etiology — Gait Disorders — Neurologic/drug therapy/etiology — Humans — MEDLINE/statistics & numerical data — Neuropsychological Tests — Psychotropic Drugs/therapeutic use|
This document has no fulltext available yet, but you can contact its author by using the form below.
|BEAUCHET, Olivier et al. Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis. In: Current Alzheimer Research, 2015, vol. 12, n° 8, p. 761-71. https://archive-ouverte.unige.ch/unige:98742|